Original Research
Published on 01 Oct 2024
Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers
in Genetics and Biomarkers of Dementia
- 2,305 views
- 2 citations



![APOE-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy](https://www.frontiersin.org/files/myhome article library/1320329/1320329_Thumb_400.jpg)





